Delivery Order SPE2DR25D1103-SPE2DR26FD732
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,220.46 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pens on November 4, 2025, with an ultimate completion date of November 5, 2025. This is a firm fixed price delivery order issued under a competitive procurement with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,267.84 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 mL pens on September 3, 2025, with completion by September 4, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order issued under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $12,870.89 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 ml pens on August 26, 2025, with an ultimate completion date of August 27, 2025. This non-set-aside contract represents a direct fulfillment order under AmerisourceBergen's existing Defense Logistics Agency contract vehicle. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a delivery order valued at $2,444.91 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pens on July 16, 2025, with completion scheduled for July 17, 2025. This competitively awarded, firm fixed-price delivery order represents a single-unit pharmaceutical transaction under AmerisourceBergen's existing contract vehicle with DLA. The contractor, headquartered in Conshohocken, Pennsylvania, will fulfill this order at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 ml pens valued at $17,343.17 with a firm fixed price contract type. This order, issued on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a competitive award with no set-aside designation. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $3,431.61 to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pens. This non-competitive, firm fixed-price delivery order is set to conclude by October 21, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier to the Department of Defense...
- The Defense Logistics Agency awarded a $1,584.34 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pens. This firm fixed-price, non-competitive delivery order is set to be completed by August 19, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government's...
- The Defense Logistics Agency awarded a delivery order valued at $28,845.70 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pens on October 29, 2025, with an ultimate completion date of October 30, 2025. This competitively awarded, firm fixed-price delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government. The product will be delivered to the company's headquarters in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $14,108.65 on September 9, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pens. This firm fixed-price delivery order, which is not set-aside and competitively awarded, is scheduled for completion by September 10, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,955.30 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pens (0.5 mL units). This firm fixed price delivery order was competitively awarded without set-aside provisions and carries an ultimate completion date of June 2, 2025. The award was made to AmerisourceBergen's Corporate Office division, with performance taking place at the company's headquarters in Conshohocken, Pennsylvania. This delivery...
- SPE2DR25D1103Indefinite Delivery Contract
- SPE2DR25D1103-SPE2DR26FD732Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,269.43 to supply Zepbound 10 mg/0.5 mL pens on a firm fixed price basis. The order was competitively awarded without set-aside designation and is scheduled for completion by November 4, 2025. AmerisourceBergen's Corporate Office, located in Conshohocken, Pennsylvania, will perform this work through its role as a critical pharmaceutical distributor supporting federal medical procurement needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor with an extensive portfolio of federal contract awards, AmerisourceBergen has demonstrated capability to meet DLA requirements across multiple therapeutic domains and fulfills medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 11/3/25 |